Arthritis as a Manifestation of Systemic Disease

Back

Practice Essentials

Musculoskeletal manifestations can be part of the presentation in many systemic conditions, but true arthritis is the initial manifestation of the underlying illness in some systemic diseases. This article focuses on systemic diseases in which an early or even the initial manifestation may be musculoskeletal in nature. These disorders predominantly include the following:

Some rheumatologic illnesses (eg, polymyalgia rheumatica, fibromyalgia, polymyositis) can also present as arthralgias without true arthritis.

Most patients who complain of joint pain and swelling, muscle pain, or limited range of motion have a primary disorder of the joint, such as rheumatoid arthritis or osteoarthritis. Less commonly, joint pains may be the chief complaint in a patient with a systemic disorder that is affecting the joints, muscles, or both. A vigilant physician must be aware of these conditions, some common and some not so common, to make an appropriate diagnosis and early referral and appropriate treatment.

Pathophysiology

Systemic illnesses can cause musculoskeletal manifestations through a variety of mechanisms. However, in many cases, the pathophysiologic basis of joint disease in these systemic illnesses is not known.

Endocrine-associated arthropathies

See the list below:

Hematologic illness arthropathies

See the list below:

Other systemic illnesses

See the list below:

Malignancy-associated arthropathies

Seronegative polyarthritis may occur as a paraneoplastic syndrome

Epidemiology

Frequency

United States

Arthritis as a manifestation of systemic disease is rare. The frequency of selected disorders that can present as arthritis is as follows:

International

The frequency of selected systemic disorders that can present as arthritis is as follows:

Mortality/Morbidity

If left undiagnosed, each of the diseases discussed in this article may result in significant morbidity and mortality, as follows:

Race

See the list below:

Sex

See the list below:

Age

See the list below:

Prognosis

Most of the arthritis get better with treatment of the underlying condition unless permanenet damage has been done due to a chronic condition.

History

Diabetes

See the list below:

Hypothyroidism

See the list below:

Hyperparathyroidism

See the list below:

Hyperthyroidism

See the list below:

Cushing disease

See the list below:

Acromegaly

See the list below:

Hyperlipidemia

See the list below:

Hemochromatosis

See the list below:

Sarcoidosis

See the list below:

Malignancies

See the list below:

HIV disease

Patients with HIV disease may report osteomyelitis, osteonecrosis, reactive arthritis, and/or psoriatic arthritis.

Physical

Hypothyroidism

See the list below:

Hyperparathyroidism

See the list below:

Diabetes

See the list below:

Cushing disease

See the list below:

Acromegaly

See the list below:

Hyperlipidemia

See the list below:

Hemochromatosis

See the list below:

Sarcoidosis

See the list below:

Laboratory Studies

A detailed review of the diagnostic workup of each of the illnesses discussed is beyond the scope of this article. The reader is referred to other articles in this journal that specifically deal with these diseases. See Hypothyroidism; Hyperparathyroidism; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Cushing Syndrome; Acromegaly; Hypercholesterolemia, Familial; Hemochromatosis; and Sarcoidosis

Several laboratory studies may be useful in patients presenting with arthritis. These tests include erythrocyte sedimentation rate (ESR), antinuclear antibodies (ANA), rheumatoid factor (RF), uric acid level, and an antistreptolysin O (ASO) titer. However, in patients with arthritis as a manifestation of one of the illnesses considered herein, the findings from these tests are generally negative or normal. Thus, if no rheumatic disease cause can be determined, the syndrome of arthritis as a manifestation of a systemic illness should be entertained. In patients with monoarticular arthritis, initial diagnostic considerations are gout, pseudogout, and infectious causes.

Hypothyroidism is usually readily diagnosed by measuring serum thyroid-stimulating hormone (TSH) and free thyroxine.

Hyperparathyroidism is usually suspected because of an elevated serum calcium level, but this value can be within the reference range. In most cases, simultaneous measurement of serum calcium and PTH is sufficient to obtain a diagnosis. Serum PTH must be measured by a proper assay, such as an intact molecule immunoradiometric assay. Serum calcium levels must be interpreted in light of the serum albumin level. An ionized calcium test can be useful in patients with low serum albumin or in patients with borderline-high total serum calcium.

Diabetes is diagnosed with fasting blood sugars. Cholesterol levels, hemoglobin A1c, and urine studies are important lab tests in the evaluation of diabetes.

Cushing disease diagnostic considerations include the following:

Acromegaly screening tests include serum growth hormone testing or serum insulinlike growth factor–1 (IGF-1) testing, although provocative testing sometimes is required to make a definitive diagnosis.

For hyperlipidemia, total serum cholesterol without regard to eating restrictions can be used as a screening test. Fractionated cholesterol values should be measured on a specimen obtained after an overnight fast.

For hemochromatosis, serum transferrin saturation and ferriitin assays are the recommended initial screening tests; patients with transferrin saturation of 45% or higher, elevated ferritin, or both should undergo HFE genotyping; full guidelines on diagnosis have been published by the American Association for the Study of Liver Diseases[8]

No definitive laboratory test is available for sarcoidosis. Leukopenia (WBC count 5%), elevated ESR, hyperglobulinemia, an elevated level of angiotensin-converting enzyme, and mild hypercalcemia all are possible laboratory abnormalities. Synovial fluid WBC count ranges from 250-6200 cells/µL with 56-100% mononuclear cells.

Imaging Studies

Plain radiographs of the hands and feet or of the affected joints may be obtained. Findings consistent with rheumatoid arthritis, such as erosions, may eliminate the need to search for nonrheumatic illnesses.

Hypothyroidism has no characteristic radiographic features.

Hyperparathyroidism may lead to the discovery of abnormalities of osteitis fibrosa cystica that are striking, but these are rarely seen today. Other features include subperiosteal resorption in the hands, wrists, and feet and resorption in the sacroiliac joints, symphysis pubis, diskovertebral junctions, and peripheral joints. Chondrocalcinosis may also be seen.

Diabetes may lead to changes in the spine. Diffuse idiopathic skeletal hyperostosis (DISH) is characterized by flowing ossification along the anterior aspect of the vertebral column, most prominent in the thoracic spine. Though present in only a few patients, Charcot joint is illustrated radiographically by sclerosis, osteophytosis, bony fractures, subluxation, and dislocation.

Cushing disease may present with osteopenia (or osteoporosis) as determined by bone mineral density measurement or with vertebral compression fractures.

Acromegaly has several characteristic radiographic features. These include increased thickening of the heel pad and widening of the articular space, which is best seen at the knee.

Hyperlipidemia has no characteristic radiographic features.

Hemochromatosis commonly manifests with cystic lesions on the metacarpal heads. Squared-off bone ends and hooklike osteophytes in the MCP joints, particularly in the second and third MCP joints, are characteristic findings. Chondrocalcinosis may also be visualized.

Sarcoidosis may affect the skeleton in a focal or generalized fashion, and either osteolytic or osteosclerotic involvement may be evident (see images below). Phalangeal cysts are often considered a helpful diagnostic clue when considering sarcoidosis.



View Image

Focal osteolytic changes seen in the phalanges in a patient with chronic sarcoid arthritis.

 

Chest radiography should be performed to rule out lung carcinomas.

Hypothyroidism, hyperparathyroidism, and hemochromatosis are associated with calcium pyrophosphate deposition (CPPD), which may be seen radiographically as chondrocalcinosis.

Histologic Findings

Sarcoidosis may have a synovial histology that is often less inflammatory in nature than rheumatoid arthritis, but, occasionally, noncaseating granulomas are observed.

Medical Care

A complete discussion of the medical therapy for each of these diseases that may have arthritis as a manifestation may be found in the article concerning that particular disease. See the following:

Treatment approaches can be summarized as follows:

Sarcoidosis treatment approaches include the following:

Surgical Care

Surgical considerations for hyperparathyroidism include the following:

In Cushing syndrome, most patients are cured with resection of the pituitary tumor via transsphenoidal surgery.

For acromegaly, surgical resection of the tumor remains the primary therapy. Unfortunately, this procedure frequently does not result in a permanent cure. Many patients not cured by surgery go on to receive radiation therapy targeting the pituitary.

Consultations

Consultations vary according to the underlying disease, as folows:

Medication Summary

For an in-depth discussion of drug therapy, see the following:

Prognosis

In general, therapy to manage the underlying illness results in improvement or complete resolution of the joint manifestations. Acute sarcoid arthritis does not cause joint damage.

In contrast, most patients with acromegaly have had the disease for many years prior to diagnosis and are left with cartilage hypertrophy and severe degenerative joint disease. The arthritis of hemochromatosis does not improve with phlebotomy.

Patient Education

For patient education resources, see the Arthritis Center and Muscle Disorders Center, as well as Knee Pain.

Author

Ritu Khurana, MD, Chief of Rheumatology, Crozer Chester Medical Center, Upland, PA

Disclosure: Nothing to disclose.

Specialty Editors

Francisco Talavera, PharmD, PhD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Lawrence H Brent, MD, Associate Professor of Medicine, Sidney Kimmel Medical College of Thomas Jefferson University; Chair, Program Director, Department of Medicine, Division of Rheumatology, Albert Einstein Medical Center

Disclosure: Stock ownership for: Johnson & Johnson.

Chief Editor

Herbert S Diamond, MD, Visiting Professor of Medicine, Division of Rheumatology, State University of New York Downstate Medical Center; Chairman Emeritus, Department of Internal Medicine, Western Pennsylvania Hospital

Disclosure: Nothing to disclose.

Additional Contributors

Kristine M Lohr, MD, MS, Professor, Department of Internal Medicine, Interim Chief, Division of Rheumatology, Director, Rheumatology Training Program, University of Kentucky College of Medicine

Disclosure: Nothing to disclose.

Acknowledgements

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous authors R Hal Scofield, MD and Linda A Zacharias, MD to the development and writing of this article.

References

  1. Mirsaeidi M, Machado RF, Schraufnagel D, Sweiss NJ, Baughman RP. Racial difference in sarcoidosis mortality in the United States. Chest. 2015 Feb. 147 (2):438-49. [View Abstract]
  2. Nell-Duxneuner V, Axmann R, Husar-Memmer E, Dallos T, Datz C, Stadlmayr A, et al. VCAM-1 serum levels are associated with arthropathy in hereditary haemochromatosis. Ann Rheum Dis. 2013 Dec. 72(12):2006-10. [View Abstract]
  3. Camacho A, Funck-Brentano T, Simão M, Cancela L, Ottaviani S, Cohen-Solal M, et al. Effect of C282Y genotype on self-reported musculoskeletal complications in hereditary hemochromatosis. PLoS One. 2015 Mar 30. 10 (3):e0122817. [View Abstract]
  4. Diabetes Home: 2014 Statistics Report. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/diabetes/data/statistics/2014StatisticsReport.html. May 15, 2015; Accessed: January 24, 2017.
  5. Helfand M, Crapo LM. Screening for thyroid disease. Ann Intern Med. 1990 Jun 1. 112(11):840-9. [View Abstract]
  6. Cagliero E, Apruzzese W, Perlmutter GS, Nathan DM. Musculoskeletal disorders of the hand and shoulder in patients with diabetes mellitus. Am J Med. 2002 Apr 15. 112(6):487-90. [View Abstract]
  7. Fam AG. Paraneoplastic rheumatic syndromes. Baillieres Best Pract Res Clin Rheumatol. 2000 Sep. 14(3):515-33. [View Abstract]
  8. [Guideline] Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011 Jul. 54(1):328-43. [View Abstract]
  9. Boswell SB, Patel DB, White EA, Gottsegen CJ, Forrester DM, Masih S, et al. Musculoskeletal manifestations of endocrine disorders. Clin Imaging. 2014 Jul-Aug. 38(4):384-96. [View Abstract]
  10. Cagliero E, Apruzzese W, Perlmutter GS, Nathan DM. Musculoskeletal disorders of the hand and shoulder in patients with diabetes mellitus. Am J Med. 2002 Apr 15. 112(6):487-90. [View Abstract]
  11. Carlsson A. Hereditary hemochromatosis: a neglected diagnosis in orthopedics: a series of 7 patients with ankle arthritis, and a review of the literature. Acta Orthop. 2009 Jun. 80(3):371-4. [View Abstract]
  12. Crispin JC, Alcocer-Varela J. Rheumatologic manifestations of diabetes mellitus. Am J Med. 2003 Jun 15. 114(9):753-7. [View Abstract]
  13. Diamond T, Stiel D, Posen S. Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors?. Ann Intern Med. 1989 Mar 15. 110(6):430-6. [View Abstract]
  14. Dorwart BB, Schumacher HR. Joint effusions, chondrocalcinosis and other rheumatic manifestations in hypothyroidism. A clinicopathologic study. Am J Med. 1975 Dec. 59(6):780-90. [View Abstract]
  15. Faraawi R, Harth M, Kertesz A, Bell D. Arthritis in hemochromatosis. J Rheumatol. 1993 Mar. 20(3):448-52. [View Abstract]
  16. Golding DN. Rheumatism and the thyroid. J R Soc Med. 1993 Mar. 86(3):130-2. [View Abstract]
  17. Jacobs-Kosmin D, DeHoratius RJ. Musculoskeletal manifestations of endocrine disorders. Curr Opin Rheumatol. 2005 Jan. 17(1):64-9. [View Abstract]
  18. Jordan JM. Arthritis in hemochromatosis or iron storage disease. Curr Opin Rheumatol. 2004 Jan. 16(1):62-6. [View Abstract]
  19. Kaminski HJ. Endocrine myopathies. Myology. 1994: 1741-2.
  20. Kapur S, McKendry RJ. Treatment and outcomes of diabetic muscle infarction. J Clin Rheumatol. 2005 Feb. 11(1):8-12. [View Abstract]
  21. Khachadurian AK. Migratory polyarthritis in familial hypercholesterolemia (type II hyperlipoproteinemia). Arthritis Rheum. 1968 Jun. 11(3):385-93. [View Abstract]
  22. Klein I, Parker M, Shebert R, Ayyar DR, Levey GS. Hypothyroidism presenting as muscle stiffness and pseudohypertrophy: Hoffmann's syndrome. Am J Med. 1981 Apr. 70(4):891-4. [View Abstract]
  23. Klemp P, Halland AM, Majoos FL, Steyn K. Musculoskeletal manifestations in hyperlipidaemia: a controlled study. Ann Rheum Dis. 1993 Jan. 52(1):44-8. [View Abstract]
  24. Lacks S, Jacobs RP. Acromegalic arthropathy: a reversible rheumatic disease. J Rheumatol. 1986 Jun. 13(3):634-6. [View Abstract]
  25. Lieberman SA, Bjorkengren AG, Hoffman AR. Rheumatologic and skeletal changes in acromegaly. Endocrinol Metab Clin North Am. 1992 Sep. 21(3):615-31. [View Abstract]
  26. McGuire JL. The endocrine system and connective tissue disorders. Bull Rheum Dis. 1990. 39(4):1-8. [View Abstract]
  27. McLean RM, Podell DN. Bone and joint manifestations of hypothyroidism. Semin Arthritis Rheum. 1995 Feb. 24(4):282-90. [View Abstract]
  28. Olynyk J, Hall P, Ahern M, Kwiatek R, Mackinnon M. Screening for genetic haemochromatosis in a rheumatology clinic. Aust N Z J Med. 1994 Feb. 24(1):22-5. [View Abstract]
  29. Smith LL, Burnet SP, McNeil JD. Musculoskeletal manifestations of diabetes mellitus. Br J Sports Med. 2003 Feb. 37(1):30-5. [View Abstract]
  30. Peyvandi F, Garagiola I, Young G. The past and future of haemophilia: diagnosis, treatments, and its complications. Lancet. 2016 Jul 9. 388 (10040):187-97. [View Abstract]

Focal osteolytic changes seen in the phalanges in a patient with chronic sarcoid arthritis.

This picture shows a 42-year-old white man who was admitted with acute back pain. In this frontal view, note the lower-face fullness that obscures his ears and the plethora of his cheeks.

Focal osteolytic changes seen in the phalanges in a patient with chronic sarcoid arthritis.

Osteolysis has left a lacy trabecular pattern in this phalanx (arrow).